Literature DB >> 15913283

Percutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgia: technique and expectations.

Douglas Kondziolka1, L Dade Lunsford.   

Abstract

OBJECT: In the management of trigeminal neuralgia (TN), physicians seek rapid and long-lasting pain relief, together with preservation of trigeminal nerve function. Percutaneous retrogasserian glycerol rhizotomy (PRGR) offers distinct advantages over other available procedures. The aim of this report was to provide details of the PRGR procedure and its expected outcome.
METHODS: The authors reviewed their experience with PRGR in 1174 patients to evaluate the procedural technique, results, and complications. Although it is clear that TN is not a static disorder but one characterized by remissions and recurrences, long-lasting pain relief was noted in 77% of patients, with 55% discontinuing all medications and 22% requiring some drug usage.
CONCLUSIONS: The authors discuss the role of PRGR in their practice, along with other procedures such as microvascular decompression and gamma knife surgery, for idiopathic or multiple sclerosis-related TN. They conclude that PRGR had distinct advantages over other procedures, which include eliminating the need for intraoperative confirmatory sensory testing, and a lower risk of facial sensory loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913283     DOI: 10.3171/foc.2005.18.5.8

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  9 in total

Review 1.  Trigeminal neuralgia.

Authors:  Joanna M Zakrzewska; Mark E Linskey
Journal:  BMJ Clin Evid       Date:  2014-10-06

2.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

3.  Chemogenetic inhibition of trigeminal ganglion neurons attenuates behavioural and neural pain responses in a model of trigeminal neuropathic pain.

Authors:  Olga A Korczeniewska; Morgan H James; Tali Eliav; Giannina Katzmann Rider; Jacqueline B Mehr; Hafsa Affendi; Gary Aston-Jones; Rafael Benoliel
Journal:  Eur J Pain       Date:  2021-12-06       Impact factor: 3.931

Review 4.  A Comprehensive Review of Trigeminal Neuralgia.

Authors:  Mark R Jones; Ivan Urits; Ken P Ehrhardt; John N Cefalu; Julia B Kendrick; Daniel J Park; Elyse M Cornett; Alan D Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2019-08-06

Review 5.  Advances in diagnosis and treatment of trigeminal neuralgia.

Authors:  Nicola Montano; Giulio Conforti; Rina Di Bonaventura; Mario Meglio; Eduardo Fernandez; Fabio Papacci
Journal:  Ther Clin Risk Manag       Date:  2015-02-24       Impact factor: 2.423

Review 6.  Trigeminal Neuralgia, Glossopharyngeal Neuralgia, and Myofascial Pain Dysfunction Syndrome: An Update.

Authors:  Mohammad Khan; Shamima Easmin Nishi; Siti Nazihahasma Hassan; Md Asiful Islam; Siew Hua Gan
Journal:  Pain Res Manag       Date:  2017-07-30       Impact factor: 3.037

7.  Recurrent Trigeminal Neuralgia: A Case Series and a Review of the Literature.

Authors:  Harsha Vardhan; Sushmitha S; Nagammai N; Saraswathi K
Journal:  Cureus       Date:  2022-02-23

8.  Radiofrequency Ablation of Pericranial Nerves for Treating Headache Conditions: A Promising Option for Patients.

Authors:  Alaa Abd-Elsayed; Laura Kreuger; Shawna Wheeler; Janet Robillard; Susanne Seeger; Douglas Dulli
Journal:  Ochsner J       Date:  2018

9.  Intraoperative CT for Neuronavigation Guidance and Confirmation of Foramen Ovale Cannulation for Glycerol Trigeminal Rhizotomy: A Technical Report and Case Series.

Authors:  Meena Thatikunta; Jessica Eaton; Mohammed Nuru; Haring J Nauta
Journal:  Cureus       Date:  2020-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.